Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHemogenyx Share News (HEMO)

Share Price Information for Hemogenyx (HEMO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.565
Bid: 1.53
Ask: 1.60
Change: 0.00 (0.00%)
Spread: 0.07 (4.575%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1.565
HEMO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TRADING UPDATES: Aurora Investment Trust beats annual benchmark

Fri, 29th Apr 2022 19:34

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Friday and not separately reported by Alliance News:

----------

Aurora Investment Trust PLC - investment company - Net asset value total return for 2021 stands at 19.1%, compared to the benchmark, the FTSE All-Share Index, which returned 18.3%. As at December 31, net asset value per share increased 19% to 253.49 pence from 213.39p the same date a year prior.

----------

Honye Financial Services Ltd - Cayman Islands-based company seeking acquisitions in financial services and financial technology - For the six months ended January 31, pretax loss narrows to GBP75,430 from GBP345,241 the same period a year prior, due to lower administrative costs and one-off other income of GBP192,922 through directors Wanbao Xu and Yu Wing Xu waiving their unpaid salaries.

----------

Ceiba Investments Ltd - investment firm dedicated to investing in Cuba, with interests in the commercial and tourism real estate sectors - As at December 31, net asset value per share declines 18% to USD1.16 from USD1.41 the same date a year before.

----------

Neometals Ltd - London-based battery materials from upstream extraction and downstream processing - As at March 31, cash balance stands at AUD65.2 million. During the three month period, for the lithium-ion battery recycling project stage 2 refining trials are complete, and at the vanadium recovery project a feasibility study for the SSAB project has advanced during the quarter and is on-track for completion by the end of June.

----------

Riverstone Energy Ltd - energy investor - Net asset value per share as at March 31 is USD14.97, up 21% from the figure at the end of 2021, driven by stronger performances from portfolio firms Onyx, Centennial, Hammerhead and Enviva. Total invested capital stands at USD70 million, while realisations came up to USD66.6 million. As at March 31, portfolio has potential unfunded commitments at March 31 of USD13 million.

----------

AEX Gold Inc - Greenland-focused gold miner - For 2021, net loss widens to CAD24.7 million from CAD12.3 million the year before, as exploration and administrative expenses continued to rise, following the completion of the 2021 exploration programme at the Nalunaq project. Exploration was also conducted at the Vagar Ridge and Nanoq Gold targets.

----------

Sovereign Metals Ltd - Perth-based rutile exploration and development company focused in Malawi - At Kasiya project, mineral resource estimate is upgraded to 1.8 billion tonnes at 1.01% rutile and 1.32% graphite, equating to 18 million tonnes of contained rutile and 23 million tonnes of contained graphite. Company has started an updated scoping study to examine the impact of higher grades, increased production volumes and increased mine life. Looking ahead, demand for high-grade titanium dioxide feedstocks continued to remain strong.

----------

Acceler8 Ventures PLC - Jersey-based acquisitions company - For the nine months ended December 31, reports pretax loss of GBP383,783, reflecting operating expenses from professional services and listing expenses. Looking ahead, company does not expects to pay dividends in the "foreseeable future" at its current stage of development.

----------

Hemogenyx Pharmaceuticals PLC - London-based biotechnology company - For 2021, pretax loss widens to GBP5.1 million from GBP2.1 million the year before, driven by a hike in finance costs to GBP2.6 million as a result of a repayment in principal and interest to settle the convertible loan facilities from Orgenesis Inc.

----------

Red Rock Resources PLC - gold explorer in Kenya and Australia, copper-cobalt in DRC - For the six months ended December 31, posts loss of GBP1.5 million, widening from GBP430,000 a year prior,as a result of higher administrative, project development and exploration expenses, following the completion of reverse circulation drill programmes in Kenya for gold and Congo for copper and cobalt.

----------

Caracal Gold PLC - gold producer with operations in East Africa - Says is making headway with three-phase operational plan is well underway at flagship Kilimapesa gold mine In Kenya, looks to increase gold production to 24,000 ounces per annum and improve efficiencies. Foe 2021, revenue up at GBP4.4 million from GBP1.0 million year before and pretax loss widens to GBP8.4 million from GBP836,000 in 2020.

----------

Sherborne Investors (Guernsey) C Ltd - funds set up with the specific policy of investing in one company, decided by investment manager Sherborne Investors Management LP, the investment vehicle of activist investor Edward Bramson - Posts net asset value per share as at December 31 at 82.93 pence per share, up 38% from 60.21p the same date a year before.

----------

Orosur Mining Inc - South American gold exploration and development company - For the third quarter ended March 31, net loss narrows to USD37,000 from USD1.2 million the same period a year prior, mainly due to a share-based compensation of USD41,000 compared to a charge of USD859,000.

----------

By Dayo Laniyan; dayolaniyan@alliancenews.com

Copyright 2022 Alliance News Limited. All Rights Reserved.

More News
13 Jul 2020 18:25

UK TRADING UPDATE SUMMARY: Mineral & Financial Invests In Ideon Tech

UK TRADING UPDATE SUMMARY: Mineral & Financial Invests In Ideon Tech

Read more
30 Jun 2020 17:07

UK DIRECTOR DEALINGS SUMMARY: TalkTalk Telecom Chair Pays GBP860,000

UK DIRECTOR DEALINGS SUMMARY: TalkTalk Telecom Chair Pays GBP860,000

Read more
26 Jun 2020 14:50

IN BRIEF: Hemogenyx Inks Investigation And Material Supply Deal

IN BRIEF: Hemogenyx Inks Investigation And Material Supply Deal

Read more
15 Jun 2020 17:54

IN BRIEF: Hemogenyx To Take Next Steps In Developing Virus Treatment

IN BRIEF: Hemogenyx To Take Next Steps In Developing Virus Treatment

Read more
2 Jun 2020 12:57

UK TRADING UPDATE SUMMARY: Novacyt Virus Test Orders At EUR135 Million

UK TRADING UPDATE SUMMARY: Novacyt Virus Test Orders At EUR135 Million

Read more
12 May 2020 18:09

Hemogenyx Pharma Placing Raises GBP2.5 Million To Fund Studies

Hemogenyx Pharma Placing Raises GBP2.5 Million To Fund Studies

Read more
1 May 2020 11:18

UK EARNINGS SUMMARY: InfraStrata Targets Breakeven At Titanic Shipyard

UK EARNINGS SUMMARY: InfraStrata Targets Breakeven At Titanic Shipyard

Read more
22 Apr 2020 15:40

UK TRADING UPDATE SUMMARY: BATM Gets EUR29 Million Ventilator Order

UK TRADING UPDATE SUMMARY: BATM Gets EUR29 Million Ventilator Order

Read more
22 Apr 2020 06:55

Hemogenyx Approved For And Issued Hu-PHEC Patent In Europe

Hemogenyx Approved For And Issued Hu-PHEC Patent In Europe

Read more
20 Feb 2020 15:15

Hemogenyx Reports Positive Test Results From Cancer Therapy Treatment

Hemogenyx Reports Positive Test Results From Cancer Therapy Treatment

Read more
11 Feb 2020 12:00

Hemogenyx Gets US Patent For Postnatal Hemogenic Endothelial Cells

Hemogenyx Gets US Patent For Postnatal Hemogenic Endothelial Cells

Read more
30 Jan 2020 15:47

Hemogenyx Raises GBP648,200 To Continue T Cell Therapy Development

Hemogenyx Raises GBP648,200 To Continue T Cell Therapy Development

Read more
15 Jan 2020 13:23

Hemogenyx Shares Jump On Promising Data From Blood Cancer Therapy

Hemogenyx Shares Jump On Promising Data From Blood Cancer Therapy

Read more
18 Nov 2019 11:51

Hemogenyx CDX Antibody Treatment Potentially "Life-Saving"

Hemogenyx CDX Antibody Treatment Potentially "Life-Saving"

Read more
23 Oct 2019 10:43

Hemogenyx signs another deal with unnamed global pharma company

(Sharecast News) - Biopharmaceutical group Hemogenyx Pharmaceuticals announced on Wednesday that its wholly-owned subsidiary Immugenyx has entered into a research agreement with a global pharmaceutical company.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.